You have 9 free searches left this month | for more free features.

Condition

Malaria (1)

Plasmodium Falciparum Malaria (1)

Severe Malaria (1)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Novartis Pharmaceuticals (2)

Medicines for Malaria Venture (1)

Collaborator

Clinical Network Services (CNS) Pty Ltd (1)

European and Developing Countries Clinical Trials Partnership (EDCTP) (1)

Q-Pharm Pty Limited (1)

QIMR Berghofer Medical Research Institute (1)

Supported by Wellcome Trust via Grant # Grant Number 207813/Z/17/Z (1)

Wellcome Trust (1)

Intervention

coartem (2)

kae609 (2)

(+)-sj000557733 (1)

iv artesunate (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

cipargamin

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Severe Malaria Trial in Worldwide (KAE609, IV Artesunate, Coartem)

Recruiting

Severe Malaria

KAE609
+2 more

Kinsasha, Democratic Republic Of Congo, Congo
+6 more

Sep 23, 2022

Malaria Trial in Worldwide (KAE609, Coartem)

Completed

Has Results

Malaria

Lambarene, Gabon
+8 more

Oct 7, 2021

Plasmodium Falciparum Malaria Trial in Brisbane, Herston ((+)-SJ000557733)

Completed

Has Results

Plasmodium Falciparum Malaria

(+)-SJ000557733

Brisbane, Queensland, Australia
+1 more

Apr 22, 2020